BDX BECTON DICKINSON & CO

NYSE bd.com


$ 184.78 $ -1.50 (-0.8 %)    

Thursday, 16-Oct-2025 18:53:29 EDT
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 185.27
$ 182.81
$ 180.00 x 5
$ 185.50 x 15
$ 178.91 - $ 185.37
$ 161.47 - $ 247.99
3,423,511
na
53.1B
$ 0.50
$ 33.50
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 11-27-2024 09-30-2024 10-K
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-01-2024 12-31-2023 10-Q
8 11-21-2023 09-30-2023 10-K
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-02-2023 12-31-2022 10-Q
12 11-22-2022 09-30-2022 10-K
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-03-2022 12-31-2021 10-Q
16 11-24-2021 09-30-2021 10-K
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-04-2021 12-31-2020 10-Q
20 11-25-2020 09-30-2020 10-K
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-06-2020 12-31-2019 10-Q
24 11-27-2019 09-30-2019 10-K
25 08-06-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-05-2019 12-31-2018 10-Q
28 11-21-2018 09-30-2018 10-K
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-06-2018 12-31-2017 10-Q
32 11-22-2017 09-30-2017 10-K
33 08-03-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-02-2017 12-31-2016 10-Q
36 11-23-2016 09-30-2016 10-K
37 08-04-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-05-2016 12-31-2015 10-Q
40 11-25-2015 09-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bd-cfo-set-to-exit-company-this-december-stock-falls

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque int...

 rbc-capital-reiterates-sector-perform-on-becton-dickinson-maintains-211-price-target

RBC Capital analyst Shagun Singh reiterates Becton Dickinson (NYSE:BDX) with a Sector Perform and maintains $211 price target.

 becton-dickinson-sees-q4-sales-5900b-vs-5912b-est

Becton Dickinson (NYSE:BDX) sees Q4 sales of $5.900 billion vs $5.912 billion analyst estimate.

 becton-dickinson-narrows-fy2025-sales-guidance-from-21800b-21900b-to-21800b-vs-21863b-est

Becton Dickinson (NYSE:BDX) narrows FY2025 sales outlook from $21.800 billion-$21.900 billion to $21.800 billion vs $21.863 bil...

 bd-enrolls-first-patient-in-xtract-registry-to-evaluate-rotarex-catheter-for-peripheral-artery-disease-treatment

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the enrollment of t...

 bd-and-opentrons-announce-multi-year-collaboration-to-integrate-robotic-liquid-handling-capabilities-into-bd-single-cell-multiomics-instruments-automating-critical-experimental-steps

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recog...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

 this-biogen-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 where-becton-dickinson-stands-with-analysts

4 analysts have expressed a variety of opinions on Becton Dickinson (NYSE: BDX) over the past quarter, offering a diverse set o...

 rbc-capital-initiates-coverage-on-becton-dickinson-with-sector-perform-rating-announces-price-target-of-211

RBC Capital analyst Shagun Singh initiates coverage on Becton Dickinson (NYSE: BDX) with a Sector Perform rating and announc...

 becton-dickinson-announces-pharmacy-automation-partnership-with-henry-ford-health-to-develop-health-system-pharmacy

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced a pharmacy automati...

 bd-provides-update-on-voluntary-recall-of-certain-bd-alaris-pump-infusion-sets

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bd-provides-update-voluntary-recall-certain-bd-alaristm-pum...

 tesla-stock-could-fall-90-tomorrow-fund-manager-still-wont-buy--heres-where-hes-investing-instead

A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of his preferred investments.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION